Tetra Bio-Pharma Inc. (CSE: TBP) (OTC: GRPOF) continues to advance towards clinical trials for its PPP001, which aims to become the first dried marijuana prescription drug.
Feb 14, 2017 Tetra Discusses Clinical Program in New Interview with CFN Media
February 9, 2017 IntelGenx and Tetra Bio-Pharma Announce the Signing of a Term Sheet for the Development and Commercialization of a Dronabinol XL Tablet
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.